Buscar Close Search
Buscar Close Search

Learn more about the Morningside Graduate School of Biomedical Sciences, a destination for collaborative, Nobel Prize-winning biomedical research.

 

Request Information

LastDecadeFunding.svg

$1.5 Billion

in NIH Funding in the last decade

NIHFundingRank.svg

#2

Medical school in New England for NIH research funding

FedResearchSupport.svg

$132,673

Average federal research support per faculty

PubPerStudent.svg

4.4

Average number of publications per student by graduation

 

Diversity and Inclusion

Our diversity efforts strengthen our capacity for vital advancements, for research discoveries that change the world, and for carrying out our shared mission of educating tomorrow’s science leaders.

 

The multiculturalism of our diverse faculty, staff, and student body, and the diverse communities we are part of, create unique opportunities for leveraging our differences as fundamental to our institution’s excellence.  Our work is a global effort enhanced by the great diversity of the local and regional communities in which we live and serve.

 

Please engage with the following videos to see our leadership's commitment to the work, and diverse students in action.

4 students posing for a photoPerspectives on Diversity, Equity and Inclusion: A conversation with UMass Chan Students

Watch Now

image1zmu7.pngPerspectives on Diversity, Equity and Inclusion: UMass Chan Leadership

Watch Now

  • gsbs-lab.jpg

    Committed to creating an environment where students drive research and innovation

News

Getting Results…
  • UMass Chan licenses RNA-based treatment for fragile X syndrome to QurAlis Corporation

    UMass Chan licenses RNA-based treatment for fragile X syndrome to QurAlis Corporation

    UMass Chan licenses potential RNA-based treatment for fragile X syndrome to QurAlis Corporation.

    Read more
  • Clinical trial participant receives first dose of UMass Chan-developed treatment for alopecia areata by Alys Pharmaceuticals

    Clinical trial participant receives first dose of UMass Chan-developed treatment for alopecia areata by Alys Pharmaceuticals

    A siRNA therapeutic for dermatological diseases developed at UMass Chan Medical School has entered the clinical trial phase.

    Read more
  • Educational Recognition Awards, Last Lecture celebrate UMass Chan’s collaborative environment

    Educational Recognition Awards, Last Lecture celebrate UMass Chan’s collaborative environment

    Mary Munson, PhD, received the 2025 Chancellors Award for Excellence in Mentoring.

    Read more
  • Connect with Us

    Learn more about the Morningside Graduate School of Biomedical Sciences

    Watch videos, take a photo tour or reach out to our admissions team

  •  071024JessicaPeura07.JPG

     

    Student Profiles

     

    PhD candidate Jessica Peura, MS, is working on deleting a specific gene in a pancreatic cancer mouse model. Peura’s research is inspired by her mother, who died of leiomyosarcoma, a rare cancer that can grow in the intestines, stomach, bladder and blood vessels.
     

    “There was not much research at the time when she was diagnosed,” Peura said. “I want to make sure that patients and their families don’t have to go through the same thing.”
     

    When Peura searched for a PhD program, she feared that the lab environment would be competitive or cutthroat. Then she interviewed at UMass Chan.
     

    "While everyone was proud of the work their lab was doing, everyone talked about how closely they worked with other labs. It was super collaborative. Everyone just seemed to love being here.”
    Read more. 

     

    Jessica Peura, MS
    PhD Candidate
    Pitarresi Laboratory
    Cancer Biology Program